Immigration reform is a topic about which many people in the United States are passionate. It involves not only concerns about economic interests, but national security as well. Our health care system is especially sensitive to alterations in immigration policy…. Read More ›
On May 25, 2016, Sen John Barrasso (R, Wyoming) introduced the Protect Continuing Physician Education and Patient Care Act of 2016, a measure intended to exempt pharmaceutical companies and medical device makers from reporting payments made to physicians for receiving… Read More ›
A recent report by an Institute of Medicine (IOM) committee on the financing and governance of graduate medical education (GME) considered an important question for health care in the United States: to what extent does the current GME system, which… Read More ›
Many leaders at academic medical centers are doing double duty, serving on the boards of pharmaceutical companies and being paid handsomely for it, finds an analysis published in JAMA today. Nearly half of the top 50 pharmaceutical companies worldwide have… Read More ›
Some medical communications companies such as Medscape/WebMD that offer online continuing medical education (CME) programs receive millions of dollars from pharmaceutical and device manufacturers and share information such as a physician’s licensing number and specialty with unnamed third parties, warn… Read More ›
It’s hard to find an article or op-ed about the implementation of Obamacare next year that doesn’t mention the looming “doctor shortage.” The reason is clear: there are too few physicians in the United States to care for today’s insured… Read More ›
The arduous track leading to the medical degree generally continues along a single path toward equally taxing residencies and fellowships. What usually follows is a lifetime of comforting and healing in private, public, or academic settings. Few professions can claim… Read More ›
